Statistics for The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells.

Total visits

views
The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells. 313

Total visits per month

views
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 0
July 2025 0

File Visits

views
nihms-734800.pdf 276
java.util.UUID:d9a5eb23-8bde-4b7e-8f60-e0bc0773f35b 41
java.util.UUID:eb607926-d32e-4ef4-a5be-0a201156943d 4

Top country views

views
United States 229
Germany 19
Sweden 6
Ukraine 6
United Kingdom 4
Russia 3
Canada 2
China 2
Italy 2
Czechia 1
Greece 1
Iran 1
Malaysia 1

Top city views

views
Wilmington 71
Ann Arbor 43
Fairfield 30
Cambridge 16
Kiez 15
Houston 9
Jacksonville 7
Washington 7
Kiev 6
White Plains 6
Stockholm 5
Lake Mary 3
Munich 3
Philadelphia 3
Saint Petersburg 3
San Francisco 3
Abingdon 2
Toronto 2
Alexandria 1
Appiano Gentile 1
Athens 1
Austin 1
Beijing 1
Brooklyn 1
Chicago 1
Gunzenhausen 1
Indianapolis 1
Irvine 1
Motala 1
Sarv 1
Scottsdale 1
Seattle 1
Seremban 1
Shenzhen 1
Slapanice 1
Vilpiano 1